QuantuMDx invests £11 million on scale-up to mass manufacture

17th December 2020

NEWCASTLE UPON TYNE, UK, 17 December 2020. QuantuMDx today announced it has invested over £11 million to scale up production of its flagship…

Read More

Staff Spotlight: Mark Ware

12th November 2020

Meet Mark Ware, Customer Care and Training Manager at QuantuMDx. When did you start working at QuantuMDx?  I started as a full-time employee at QuantuMDx in…

Read More

Assay Development Lead

15th October 2020

We’re looking for a proven leader, an expert in assay design and development, skilled in cutting edge scientific techniques and someone who can take a…

Read More

Scaling up in a pandemic: A Q&A with Andy Whittle

15th October 2020

Andy Whittle, VP Manufacturing at QuantuMDx, discusses the highs and lows of scaling up to manufacture, during a global pandemic. What is your background?  Andy…

Read More

QuantuMDx E-poster presentation: ECCVID 2020

7th October 2020

Our Head of Assay Feasibility, Dr John Tyson presented an e-poster at ECCVID last month – the ESCMID Conference on Coronavirus. The e-poster focuses on …

Read More

White paper: QuantuMDx SARS-CoV-2 RT-PCR Detection Assay – clinical performance evaluation

19th August 2020

Title: QuantuMDx SARS-CoV-2 RT-PCR Detection Assay – design, analytical and multi-centre evaluation of clinical performance White paper overview: After completing the development of our…

Read More

Research Scientist

6th August 2020

We are looking for an experienced Assay Research Scientist with a strong background in molecular biology/diagnostics to take a key role in development projects, focusing on our Q-POC™ platform and diagnostic assays.

Read More

Staff Spotlight: Sam Bhatt

26th June 2020

Sam Bhatt is a Programme Manager at QuantuMDx. Here, Sam tells us more about himself and gives us an insight into his role. When did…

Read More

QuantuMDx attains CE-IVD marking for SARS-CoV-2 Test

8th June 2020

QuantuMDx Group today announces its SARS-CoV-2 detection assay has been CE-IVD marked under the In Vitro Diagnostics Directive (98/79/EC), enabling use within the European…

Read More

QuantuMDx launches rapid, sensitive SARS-CoV-2 test

1st May 2020

QuantuMDx Group today announces the launch of its sensitive SARS-CoV-2 assay for laboratory use, which delivers a result in approximately 70 minutes. Working with British…

Read More